A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Pfizer
Pfizer
National Institutes of Health Clinical Center (CC)
Coherus Oncology, Inc.
Revolution Medicines, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
AstraZeneca
Roswell Park Cancer Institute
Merck Sharp & Dohme LLC
City of Hope Medical Center
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.
Taiho Pharmaceutical Co., Ltd.